Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Accured Expenses (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Change in Accured Expenses for 6 consecutive years, with -$1.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 406.93% year-over-year to -$1.3 million, compared with a TTM value of $255000.0 through Dec 2025, down 91.07%, and an annual FY2025 reading of $255000.0, down 91.07% over the prior year.
  • Change in Accured Expenses was -$1.3 million for Q4 2025 at Viemed Healthcare, down from $3.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.6 million in Q3 2025 and bottomed at -$3.7 million in Q2 2021.
  • Average Change in Accured Expenses over 5 years is $329900.0, with a median of $73500.0 recorded in 2021.
  • The sharpest move saw Change in Accured Expenses soared 3559.55% in 2022, then plummeted 406.93% in 2025.
  • Year by year, Change in Accured Expenses stood at -$311000.0 in 2021, then crashed by 99.68% to -$621000.0 in 2022, then soared by 240.58% to $873000.0 in 2023, then tumbled by 50.4% to $433000.0 in 2024, then tumbled by 406.93% to -$1.3 million in 2025.
  • Business Quant data shows Change in Accured Expenses for VMD at -$1.3 million in Q4 2025, $3.6 million in Q3 2025, and $1.1 million in Q2 2025.